ArticleDiagnostics (Basel, Switzerland)2025

Delta-Radiomics Biomarker in Colorectal Cancer Liver Metastases Treated with Cetuximab Plus Avelumab (CAVE Trial).

Valerio Nardone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.